Philip M Long
Overview
Explore the profile of Philip M Long including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
1332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Long P, Servedio R
Neural Comput
. 2022 May;
34(6):1488-1499.
PMID: 35534009
van Rooyen, Menon, and Williamson (2015) introduced a notion of convex loss functions being robust to random classification noise and established that the "unhinged" loss function is robust in this...
2.
Bartlett P, Long P, Lugosi G, Tsigler A
Proc Natl Acad Sci U S A
. 2020 Apr;
117(48):30063-30070.
PMID: 32332161
The phenomenon of benign overfitting is one of the key mysteries uncovered by deep learning methodology: deep neural networks seem to predict well, even with a perfect fit to noisy...
3.
Long P, Sedghi H
Neural Comput
. 2019 Oct;
31(12):2562-2580.
PMID: 31614106
We analyze the joint probability distribution on the lengths of the vectors of hidden variables in different layers of a fully connected deep network, when the weights and biases are...
4.
Bartlett P, Helmbold D, Long P
Neural Comput
. 2019 Jan;
31(3):477-502.
PMID: 30645179
We analyze algorithms for approximating a function mapping to using deep linear neural networks, that is, that learn a function parameterized by matrices and defined by . We focus on...
5.
Nam S, Park J, Ramasamy A, Shevade S, Islam A, Long P, et al.
Hepatology
. 2005 Sep;
42(4):809-18.
PMID: 16175600
Progression of hepatocellular carcinoma (HCC) is a stepwise process that proceeds from pre-neoplastic lesions--including low-grade dysplastic nodules (LGDNs) and high-grade dysplastic nodules (HGDNs)--to advanced HCC. The molecular changes associated with...
6.
Vega V, Ruan Y, Liu J, Lee W, Wei C, Se-Thoe S, et al.
BMC Infect Dis
. 2004 Sep;
4:32.
PMID: 15347429
Background: The SARS coronavirus is the etiologic agent for the epidemic of the Severe Acute Respiratory Syndrome. The recent emergence of this new pathogen, the careful tracing of its transmission...
7.
Neo S, Leow C, Vega V, Long P, Islam A, Lai P, et al.
Hepatology
. 2004 Apr;
39(4):944-53.
PMID: 15057898
The severity of hepatocellular carcinoma (HCC) and the lack of good diagnostic markers and treatment strategies have rendered the disease a major challenge. Previous microarray analyses of HCC were restricted...
8.
Fortunel N, Otu H, Ng H, Chen J, Mu X, Chevassut T, et al.
Science
. 2003 Oct;
302(5644):393.
PMID: 14563990
No abstract available.
9.
Sotiriou C, Neo S, McShane L, Korn E, Long P, Jazaeri A, et al.
Proc Natl Acad Sci U S A
. 2003 Aug;
100(18):10393-8.
PMID: 12917485
Comprehensive gene expression patterns generated from cDNA microarrays were correlated with detailed clinico-pathological characteristics and clinical outcome in an unselected group of 99 node-negative and node-positive breast cancer patients. Gene...
10.
Ruan Y, Wei C, Ee A, Vega V, Thoreau H, Su S, et al.
Lancet
. 2003 Jun;
361(9371):1779-85.
PMID: 12781537
Background: The cause of severe acute respiratory syndrome (SARS) has been identified as a new coronavirus. Whole genome sequence analysis of various isolates might provide an indication of potential strain...